Asia-Pacific Veterinary Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Asia-Pacific Veterinary Healthcare market is segmented by Product, Animal Type, and Geography

Market Snapshot

bare-metal-cloud-market_Market Summary
Study Period:

2018 - 2026

Base Year:



10 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Asia Pacific veterinary healthcare market is projected to have significant growth owing to increasing risk of emerging zoonosis and rising awareness regarding the animal health in Asia Pacific. Other factors responsible for the growth of the market studied include an increase in the number of farm animals and growing technological advancements in animal healthcare.

According to the National Dairy Development Board, in 2017, in India, the cattle population was valued at 156.7 million and the nation has one of the largest animal husbandry sectors in the world, along with the largest livestock population (520.6 million). However, the use of counterfeit medicines, lack of infrastructure, and funding are restraining the growth of the market studied.

Scope of the Report

As per the scope of this report, the AsiaPacific veterinary healthcare market comprises of therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine.

By Product
By Therapeutics
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Other Animals
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Molecular Diagnostics Segment is expected to Have Significant Market Share

  • The veterinary molecular diagnostics segment is expected to witness growth over the forecast period, due to the increasing academic research activities pertaining to veterinary molecular diagnostics and investigational techniques, primarily to target epidemic-like conditions in companion and farm animals.
  • Furthermore, there is an increase in the application of molecular diagnostic techniques, primarily for the identification of bacterial diseases, like Brucella, through enzyme-linked immunosorbent assay (ELISA), Rose Bengal Plate Test (RBPT), and PCR-based diagnosis.
  • For instance, the department of veterinary medical sciences at the Graduate School of Agricultural and Life Sciences, University of Tokyo, is involved in conducting advanced research at molecular, cellular, and in vivo levels, in order to fully understand vital processes of normal and diseased animals. Though the market is in the nascent stage, there are tremendous opportunities for market growth, primarily due to increased activity in academic research and government funding.
  • On the other hand medical feed additives in therapeutics segment projected to hold the notable market growth due to the growing awareness, recent product launches and expansion of multinational companies accross Asia.
  • For instance in march 2017, Evonik has expanded its portfolio in Asia with the probiotic Ecobiol. It will be launched at VIV Asia in Bangkok. Ecobiol is designed for the use in poultry production and aquaculture. This is likely to boost the segment growth over the forecast period.
  • Morover, increasing animal population, adoption in emerging countries such as India and initiatives by various governments across the Asia projected to propel the market growth over the future.
apac animal 2.png

To understand key trends, Download Sample Report

Competitive Landscape

The players in the Asia-Pacific veterinary healthcare market are primarily focusing on various growth strategies, such as collaborations, partnerships, agreements, mergers, and acquisitions, in order to enhance their market presence. Major market players include Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco, Merck Animal Health, and Zoetis and Virbac Corporation, among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

      1. 4.1.1 Advanced Technology is Leading to Innovations in Animal Healthcare

      2. 4.1.2 Increasing Productivity at the Risk of Emerging Zoonosis

    2. 4.2 Market Restraints

      1. 4.2.1 Increasing Cost of Animal Testing and Veterinary Services

      2. 4.2.2 Lack of Infrastructure and Funding

      3. 4.2.3 Use of Counterfeit Medicines

    3. 4.3 Porter's Five Forces Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. Vaccines

        2. Parasiticides

        3. Anti-infectives

        4. Medical Feed Additives

        5. Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. Immunodiagnostic Tests

        2. Molecular Diagnostics

        3. Diagnostic Imaging

        4. Clinical Chemistry

        5. Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific


    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Inc.

      2. 6.1.2 Merck & Co., Inc.

      3. 6.1.3 Vetoquinol

      4. 6.1.4 Elanco

      5. 6.1.5 Bayer AG

      6. 6.1.6 ceva Santé Animale

      7. 6.1.7 Virbac

      8. 6.1.8 IDEXX Laboratories

      9. 6.1.9 Phibro Animal Health

      10. 6.1.10 Boehringer Ingelheim

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Veterinary Healthcare Market market is studied from 2018 - 2026.

The Asia-Pacific Veterinary Healthcare Market is growing at a CAGR of 10% over the next 5 years.

  • Merck Animal Health
  • Vetoquinol
  • Elanco
  • Ceva Animal Health Inc.
  • Boehringer Ingelheim International GmbH

Are the major companies operating in Asia-Pacific Veterinary Healthcare Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!